UCSF

The Laboratory for Genomics Research offers Innovation Awards

The Laboratory for Genomics Research (LGR) is offering one-year LGR Innovation Awards to faculty members at UC San Francisco and UC Berkeley to develop highly innovative ideas into early proofs-of-concept across the field of functional genomics.

The LGR is a hybrid academic-industry partnership between UCSF, UC Berkeley, and the pharmaceutical company GSK. It was founded in 2019 by Jennifer Doudna, PhD, a co-inventor of CRISPR technology and 2020 Nobel Prize Laureate in Chemistry; Jonathan Weissman, PhD; and Hal Barron, MD.

The goal of the LGR Innovation Awards is to "identify and support the development of broadly applicable novel platform technologies or methods rather than the applications of existing ones," which span CRISPR genome editing; advanced preclinical model and assay technologies; high throughput screening technologies; and computational biology & statistics.

The award provides $100,000 over one year as well as access to facilities, equipment, reagents, and the expertise of LGR staff. The application deadline is October 1, 2021.

For more information and to apply, visit the LGR Innovation Awards request for proposals.


About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.